Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Clauss Science Support AB
AB
Active
Org 5593880049
Parkvägen 4
Business and other management consultancy activities · NACE 7020
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 1,8M
-3% vs 2024
EBITDA margin
29.6%
+8% vs 2024
Equity ratio
70.1%
Financial strength
Net profit 2025
SEK 436K
+7% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
0M
2023
0M
0%
2024
1M
+100%
2025
Key figures
Annual report 2025
Revenue
SEK 1,8M
-3%
EBITDA
SEK 534K
+8%
Net profit
SEK 436K
+7%
Total assets
SEK 997K
+38%
Equity
SEK 699K
+48%
Employees
1
—
Company information
Legal name
Clauss Science Support AB
Org number
5593880049
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
5 juli 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget skall bedriva konsultverksamhet inom läkemedelsutveckling.
Contact
Address
Parkvägen 4
Email
adam@clauss.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Eslöv
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
1M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
1M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
1 119
1 856
1 802
Staff expenses
−594
−1 064
−1 079
EBITDA
309
496
534
Depreciation & amort.
—
—
—
EBIT
309
496
534
Net financials
1
20
17
Profit before tax
310
516
551
Tax
−65
−109
−115
Net profit
245
407
436
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
360
724
997
Equity
270
472
699
Long-term debt
—
—
—
Short-term debt
91
252
298
Total debt
91
252
298
Financial ratios
5-year trend
EBITDA margin
29.6%
This company
15.8%
Market median
+87% vs market
2023
2025
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
2023
2025
Return on equity
62.4%
This company
18.4%
Market median
+239% vs market
2023
2025
Net profit margin
24.2%
This company
8.1%
Market median
+199% vs market
2023
2025
Asset turnover
1.81×
This company
1.12×
Market median
+62% vs market
2023
2025
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-05 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AJ
Adam Jochum Clauss
Board of Directors
2022
KG
Kajsa G V Sigfridsson Clauss
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Clauss Science Support AB also hold positions in
0
other companies.
Person
Role here
Other companies
Adam Jochum Clauss
Board of Directors
0 companies
Kajsa G V Sigfridsson Clauss
Board of Directors
0 companies